ClinicalTrials.Veeva

Menu
T

The Queen Elizabeth Hospital | Rheumatology Department

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Tislelizumab
Bevacizumab
Pembrolizumab

Parent organization

This site is a part of The Queen Elizabeth Hospital

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 2 total trials

A Study of ABT-301 Plus Tislelizumab With Bevacizumab in pMMR/Non-MSI-H Locally Advanced or mCRC

The goal of this clinical trial is to evaluate the safety and tolerability of escalating doses of ABT-301 in combination with fixed doses of tisleliz...

Enrolling
Colorectal Cancer (CRC)
Colorectal Cancer (Diagnosis)
Drug: Bevacizumab (Avastin)
Drug: ABT-301

This is a multicenter, open-label, Phase 1 study to assess the effects of DCSZ11 as a monotherapy and in combination in patients with advanced or met...

Enrolling
Advanced or Metastatic Solid Tumors
Drug: Pembrolizumab
Drug: Doxorubicin

Trial sponsors

A
D

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems